pubmed-article:12357148 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C0007202 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C0019120 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C1155266 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
pubmed-article:12357148 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:12357148 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12357148 | pubmed:dateCreated | 2002-10-1 | lld:pubmed |
pubmed-article:12357148 | pubmed:abstractText | Cardiac surgery involving cardiopulmonary bypass (CPB) leads to fulminant activation of the hemostatic-inflammatory system. The authors hypothesized that heparin concentration-based anticoagulation management compared with activated clotting time-based heparin management during CPB leads to more effective attenuation of hemostatic activation and inflammatory response. In a randomized prospective study, the authors compared the influence of anticoagulation with a heparin concentration-based system (Hepcon HMS; Medtronic, Minneapolis, MN) to that of activated clotting time-based management on the activation of the hemostatic-inflammatory system during CPB. | lld:pubmed |
pubmed-article:12357148 | pubmed:language | eng | lld:pubmed |
pubmed-article:12357148 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12357148 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12357148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12357148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12357148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12357148 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12357148 | pubmed:month | Oct | lld:pubmed |
pubmed-article:12357148 | pubmed:issn | 0003-3022 | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:HetzerRolandR | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:FischerThomas... | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:KueblerWolfga... | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:KosterAndreas... | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:PrausMichaelM | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:KuppeHermanH | lld:pubmed |
pubmed-article:12357148 | pubmed:author | pubmed-author:HaberzettlHel... | lld:pubmed |
pubmed-article:12357148 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12357148 | pubmed:volume | 97 | lld:pubmed |
pubmed-article:12357148 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12357148 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12357148 | pubmed:pagination | 837-41 | lld:pubmed |
pubmed-article:12357148 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:meshHeading | pubmed-meshheading:12357148... | lld:pubmed |
pubmed-article:12357148 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12357148 | pubmed:articleTitle | Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. | lld:pubmed |
pubmed-article:12357148 | pubmed:affiliation | Department of Anesthesia, Deutsches Herzzentrum, and Institute of Physiology, Freie Universität, Berlin, Germany. Koster@dhzb.de | lld:pubmed |
pubmed-article:12357148 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12357148 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12357148 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:12357148 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12357148 | lld:pubmed |